FDA Accepts Application for GSK’s Chronic Kidney Disease Drug
FDA Proposes Ban on All Flavored Cigarettes, Cigars
Moderna Appoints Arpa Garay as Chief Commercial Officer
FDA Considers New Strategy to Boost Safe Opioid Disposal
GSK Enters $1.9B Agreement to Develop Rare Cancer Treatments
FDA Issues EUA to First COVID-19 Test Using Breath Samples
FDA Grants Priority Review for Non-Small Cell Lung Cancer Drug
Sanofi’s BTK Inhibitor Effective in Immune Thrombocytopenia Patients
FDA Lifts Hold on Gilead’s MDS, AML Clinical Trials
Moderna Doses Participants in Study of Two Influenza mRNA Vaccines
WHO Recommends Johnson & Johnson’s COVID-19 Vaccine for Booster Use
Sanofi Launches First-in-Pharma Diversity, Equity, Inclusion Board
FDA Issues Draft Guidance to Increase Clinical Trial Diversity
Eli Lilly’s Retevmo Helps Non-Small Cell Lung Cancer Patients
Pfizer to Acquire BioPharma Company to Develop RSV Therapeutics
Michigan Blue Launches Pharmacogenomics Precision Medicine Program
FDA Approves ViiV Healthcare’s HIV-1 Treatment for Children
Sandoz Expands Collaboration in Antimicrobial Resistance Fight
Pfizer Appoints David M. Denton as CFO, Executive Vice President
Merck Expands Broad Access to HPV Vaccines Globally
Moderna Launches Foundation to Promote Access to Quality Care
New Toolkit Supports Digital Endpoints in Drug Development
Roche’s Small Cell Lung Cancer Antibody Fails in Phase 3 Trial
FDA Expands Indication of Long-Acting Injectable HIV Treatment
AstraZeneca to Share New Data on Oncology Treatment Landscape
Gilead Grants $24M to Improve Access, Care for HIV Communities
Merck’s CMV Drug Lowers Reactivation by 88% After Cell Transplant
Pfizer’s S1P Modulator Drug Helps Ulcerative Colitis Patients